My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 703 / DOI: 10.3332/ecancer.2016.703

Conference Report

Biomarkers come of age: PD1 in the frontline and cell cycle therapy swells the ranks of personalised therapy in the European Society of Medical Oncology (ESMO) congress, Copenhagen, 7–10 October 2016

After years of trials, Programmed Death Ligand and Receptor targeting finally debuts as a firstline therapy in combination and as a single agent regimen at the 2016 European Society of Medical Oncology (ESMO) Congress. The meeting brought together 20,522 attendees, from over 120 countries, to share updates and novel technologies from a wide swathe of oncology research. This year’s theme, From Disease Treatment to Patient Care, was matched by abstract presentations starting from inception of care regimens to new standards of care in high-risk patient subgroups, to wellbeing of care providers, and finally the funding obstacles at each continental level.

Keywords: ESMO, checkpoint immunotherapy, lung cancer, bladder cancer, ovarian cancer, breast cancer, CDK, fulvestrant, PD-1, PD-L1, PARP inhibition, urothelial cancer

Loading Article Metrics ... Please wait

Related videos

Related articles

Image Report: Brachytherapy and anterior segment imaging in iris melanoma

Abstract | Full Article | PDF Published: 18 Apr 2017 / DOI: 10.3332/ecancer.2017.734

Case Report: Unusual tumour ablations: report of difficult and interesting cases

Abstract | Full Article | PDF Published: 18 Apr 2017 / DOI: 10.3332/ecancer.2017.733

Conference Report: Highlights from the 15th St Gallen International Breast Cancer Conference 15–18 March, 2017, Vienna: tailored treatments for patients with early breast cancer

Abstract | Full Article | PDF Published: 07 Apr 2017 / DOI: 10.3332/ecancer.2017.732

Case Report: Penile melanoma: a 20-Year analysis of six patients at the National Cancer Institute of Peru, Lima

Abstract | Full Article | PDF | Spanish Published: 04 Apr 2017 / DOI: 10.3332/ecancer.2017.731

Conference Report: Highlights from the first ecancer–Liga Colombiana contra el Cancer conference, 17–18 November 2016, Bogota, Colombia

Abstract | Full Article | PDF | Spanish Published: 28 Mar 2017 / DOI: 10.3332/ecancer.2017.730



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence